BlueAllele® Corporation Continues to Advance Therapeutic Approaches Using Novel Gene Correction Technologies and Secures Third Patent from the USPTO View more
BlueAllele Launches PALIDON™ Gene Editing Technology to Discover and Develop Therapies for Genetic Diseases View more